POC testing suitable for respiratory virus:
This article was originally published in Clinica
UK researchers have concluded that testing for the pneumonia causing respiratory syncytial virus (RSV) in the emergency room is viable as well as cost-effective. Some 98 children with symptoms were tested using Abbott's TestPack RSV enzyme immunoassay and the results compared with laboratory immunofluorescence testing. "The positive result of [the Abbott] test is trustworthy and does not require laboratory confirmation but a negative result needs further investigation," the researchers, from the Royal Hospital for Sick Children in Edinburgh, report in the British Medical Journal (July 31).
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.